Carboxylated graphene quantum dots inhibit Aβ42 and α-synuclein co-aggregation via competitive N-terminal targeting: An REMD study
Fields of Study & Subjects
Alzheimer's disease research and treatments
Parkinson's Disease Mechanisms and Treatments
Carbon and Quantum Dots Applications
Publication details
- Journal / source
- Computational and Theoretical Chemistry
- Volume
- 1257
- Pages
- 115678–115678
- Publication date
- 15 January 2026
- Language
- EN